These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3309607)

  • 1. [Epidemiology of Hodgkin's disease: familial occurrence. Exogenous factors?].
    Dörken H
    Med Klin (Munich); 1987 Aug; 82(17):551-7. PubMed ID: 3309607
    [No Abstract]   [Full Text] [Related]  

  • 2. [The epidemiology of lymphogranulomatosis (Hodgkin's disease)].
    Dörken H
    Arch Geschwulstforsch; 1969; 34(4):322-35. PubMed ID: 5397539
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial Hodgkin's disease. Occurrence in two brothers.
    Thorling K
    Dan Med Bull; 1973 Mar; 20(2):61-3. PubMed ID: 4688461
    [No Abstract]   [Full Text] [Related]  

  • 4. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin's disease in four siblings.
    Barretto OC; Morioka H; Terra VM; Bubman I; Souza LF; Bellis ND; Carvalho KT; Machado JC
    Ann Pathol; 1984; 4(3):241-4. PubMed ID: 6477690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for familial aggregation in Hodgkin's disease.
    Katin MJ
    N Engl J Med; 1977 Apr; 296(16):940-1. PubMed ID: 846516
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Familial Hodgkin's disease.
    Doerken H
    Lancet; 1974 Dec; 2(7894):1463. PubMed ID: 4140388
    [No Abstract]   [Full Text] [Related]  

  • 8. [Familial incidence of Hodgkin's disease].
    Vettori G; Erle G
    Arch Maragliano Patol Clin; 1967; 23(3):391-4. PubMed ID: 5632829
    [No Abstract]   [Full Text] [Related]  

  • 9. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological classification and occurrence of Hodgkin's disease].
    Lennert K; Mohri N
    Internist (Berl); 1974 Feb; 15(2):57-65. PubMed ID: 4599809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Familial occurence of Hodgkin's disease].
    Oliva H; Rapado A; APADO A; De La Barreda P; Casado Pérez S; Plaza Pérez JJ; Sabando Suárez P; THOL ; LYMPH NODES/PATHOL ; SPLEEN/PATHOL ; SPAIN
    Rev Clin Esp; 1974 Dec; 135(5):417-23. PubMed ID: 4457995
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
    Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal abnormalities in Hodgkin's disease are not restricted to Hodgkin/Reed-Sternberg cells.
    Jansen MP; Hopman AH; Haesevoets AM; Gennotte IA; Bot FJ; Arends JW; Ramaekers FC; Schouten HC
    J Pathol; 1998 Jun; 185(2):145-52. PubMed ID: 9713340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial Hodgkin's disease in two siblings.
    Thavaraj V; Kumar R; Arya LS
    Indian Pediatr; 2002 Jan; 39(1):79-83. PubMed ID: 11805358
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiology of Hodgkin's disease: a review.
    Cartwright RA; Watkins G
    Hematol Oncol; 2004 Mar; 22(1):11-26. PubMed ID: 15152367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems and promises of targeted therapy for Hodgkin's lymphoma.
    Re D; Thomas RK; Zander T; Diehl V
    Nat Clin Pract Oncol; 2005 Jan; 2(1):2-3. PubMed ID: 16264830
    [No Abstract]   [Full Text] [Related]  

  • 18. International symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 4. Synthesis and epidemiological implications. Invited discussion: Synthesis and epidemiologic implications.
    Schneiderman MA
    Natl Cancer Inst Monogr; 1973 May; 36():169-70. PubMed ID: 4744575
    [No Abstract]   [Full Text] [Related]  

  • 19. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
    Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Symposium on Hodgkin's disease. Session 1. Epidemiology and etiology. Part 3. Immunology. Invited discussion: Genetic factors in immune responsivess.
    McDevitt HO
    Natl Cancer Inst Monogr; 1973 May; 36():135-6. PubMed ID: 4270376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.